1. Home
  2. AYTU vs REE Comparison

AYTU vs REE Comparison

Compare AYTU & REE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AYTU
  • REE
  • Stock Information
  • Founded
  • AYTU N/A
  • REE 2011
  • Country
  • AYTU United States
  • REE Israel
  • Employees
  • AYTU N/A
  • REE N/A
  • Industry
  • AYTU Biotechnology: Pharmaceutical Preparations
  • REE Auto Manufacturing
  • Sector
  • AYTU Health Care
  • REE Consumer Discretionary
  • Exchange
  • AYTU Nasdaq
  • REE Nasdaq
  • Market Cap
  • AYTU 18.8M
  • REE 22.4M
  • IPO Year
  • AYTU N/A
  • REE N/A
  • Fundamental
  • Price
  • AYTU $2.37
  • REE N/A
  • Analyst Decision
  • AYTU Strong Buy
  • REE Strong Buy
  • Analyst Count
  • AYTU 3
  • REE 2
  • Target Price
  • AYTU $9.17
  • REE $11.75
  • AVG Volume (30 Days)
  • AYTU 393.1K
  • REE 135.6K
  • Earning Date
  • AYTU 11-12-2025
  • REE 09-16-2025
  • Dividend Yield
  • AYTU N/A
  • REE N/A
  • EPS Growth
  • AYTU N/A
  • REE N/A
  • EPS
  • AYTU N/A
  • REE N/A
  • Revenue
  • AYTU $66,382,000.00
  • REE $183,000.00
  • Revenue This Year
  • AYTU N/A
  • REE $6,661.20
  • Revenue Next Year
  • AYTU $19.03
  • REE $2,240.01
  • P/E Ratio
  • AYTU N/A
  • REE N/A
  • Revenue Growth
  • AYTU 1.84
  • REE N/A
  • 52 Week Low
  • AYTU $0.95
  • REE $0.53
  • 52 Week High
  • AYTU $2.82
  • REE $11.72
  • Technical
  • Relative Strength Index (RSI)
  • AYTU 57.62
  • REE 57.71
  • Support Level
  • AYTU $1.65
  • REE $0.68
  • Resistance Level
  • AYTU $1.98
  • REE $0.84
  • Average True Range (ATR)
  • AYTU 0.16
  • REE 0.07
  • MACD
  • AYTU 0.03
  • REE 0.00
  • Stochastic Oscillator
  • AYTU 70.30
  • REE 57.00

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.

About REE REE Automotive Ltd.

REE Automotive Ltd is an automotive technology company focused on building commercial electric vehicles controlled fully by-wire. The company is in early stages of commercialization and develop and produce software-defined vehicle (SDV) technology that manages vehicle operations and features through proprietarily-developed software. The company has geographical preference in Israel, Germany, United States, United Kingdom, and other regions.

Share on Social Networks: